Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Tenapil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 5 USDMF, 2 KDMF, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

19 FDF Dossiers, 16 FDA Orange Book, 1 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 18 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Capital Farma, 2 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 5 Corel Pharma Chem, 4 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 12 Kerry, 1 Keval Exports, 1 Lonza Capsugel, 5 Lubrizol Life Science Health, 13 Microlex e.U, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 34 Direct Compression, 25 Disintegrants & Superdisintegrants, 25 Granulation, 20 Thickeners and Stabilizers, 19 Chewable & Orodispersible Aids, 17 Solubilizers, 15 Controlled & Modified Release, 15 Co-Processed Excipients, 14 Taste Masking, 14 Lubricants & Glidants, 7 Parenteral, 6 Topical, 6 Coating Systems & Additives, 3 Film Formers & Plasticizers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Vegetarian Capsules, 1 API Stability Enhancers

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices

3 Regulatory FDF Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	Daehe Chemical	South Korea	Samhwa Biopharm Co., Ltd.	20090617-97-E-84-02	Diethylpropion hydrochloride	2009-06-17	Samhwa Biopharm Co., Ltd.	South Korea	150 Hyeopnyeop-ro, Siheung-si, Gyeonggi-do
31/03/2026	Olon S.p.A	Italy	Sam-O Pharmaceutical Co., Ltd.	20080204-97-E-39-01	Diethylpropion hydrochloride	2008-02-05	Olon SpA	Italy	Via Milano, 186 20024 Garbagnate Milanese (MI), Italy

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Tenapil

Tenapil

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers

5 USDMF

2 KDMF

3 NDC API

5 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

19 FDF Dossiers

16 FDA Orange Book

1 South Africa

2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

18 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Capital Farma

2 Cerata Pharmaceuticals LLP

2 Dr. Paul Lohmann GmbH & Co. KGaA

1 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

14 BASF

5 Corel Pharma Chem

4 DFE Pharma

6 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

12 Kerry

1 Keval Exports

1 Lonza Capsugel

5 Lubrizol Life Science Health

13 Microlex e.U

2 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

15 Roquette

1 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

2 Ulanqab Kema New Material

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders

34 Direct Compression

25 Disintegrants & Superdisintegrants

25 Granulation

20 Thickeners and Stabilizers

19 Chewable & Orodispersible Aids

17 Solubilizers

15 Controlled & Modified Release

15 Co-Processed Excipients

14 Taste Masking

14 Lubricants & Glidants

7 Parenteral

6 Topical

6 Coating Systems & Additives

3 Film Formers & Plasticizers

2 Emulsifying Agents

2 Rheology Modifiers

TABLET;ORAL - 25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons